CRISPR Therapeutics (CRSP)
(Delayed Data from NSDQ)
$45.92 USD
-0.87 (-1.86%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $45.89 -0.03 (-0.07%) 4:46 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-1.45 | 0.00% |
Earnings Summary
For their last quarter, CRISPR Therapeutics (CRSP) reported earnings of -$1.49 per share, missing the Zacks Consensus Estimate of -$1.37 per share. This reflects a negative earnings surprise of 8.76%. Look out for CRSP's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$1.45 per share, reflecting a year-over-year decrease of 2.84%.
Earnings History
Price & Consensus
Zacks News for CRSP
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know
CRSP: What are Zacks experts saying now?
Zacks Private Portfolio Services